{"nct_id":"NCT06628310","title":"A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-12-13","start_date_type":"ACTUAL","primary_completion_date":"2030-10","primary_completion_date_type":"ESTIMATED","completion_date":"2030-10","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}